Hormonal status and inflammation in menopausal women with bronchial asthma

Introduction. At least 348 million patients worldwide suffer from bronchial asthma (BA). It has been established that in women, hormonal status, namely female sex hormones such as estradiol and progesterone, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), contributes to the...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Barkova, V. I. Trofimov
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2025-06-01
Series:Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:
Online Access:https://www.sci-notes.ru/jour/article/view/1128
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689607279476736
author A. V. Barkova
V. I. Trofimov
author_facet A. V. Barkova
V. I. Trofimov
author_sort A. V. Barkova
collection DOAJ
description Introduction. At least 348 million patients worldwide suffer from bronchial asthma (BA). It has been established that in women, hormonal status, namely female sex hormones such as estradiol and progesterone, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), contributes to the course and development of BA.The objective was to evaluate hormonal status and inflammation indices in menopausal women suffering from BA.Methods and materials. Our study involved 71 patients suffering from mild to moderate BA, outside of exacerbation of the disease, in menopause. The control group consisted of 16 healthy menopausal women. All subjects underwent determination of the level of estradiol, progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, cortisol, immunoglobulin E, IL-1α, IL-4 and IL-8, nitric oxide (FENO), cytological examination of spontaneous sputum, as well as spirometry with a bronchodilator.Results. In the group of patients with BA, the level of estradiol was almost 2 times lower compared to the control group (p<0.05), while the level of progesterone was, on the contrary, lower in the control group compared to patients with BA (p<0.05). The level of prolactin was almost 2 times lower in the studied group of patients with BA compared to the control group (p<0.05). A higher level of FSH was found in the group of patients with BA compared to the control group (p<0.05), LH levels were practically the same in the study group and the control group, the LH/FSH level was significantly lower in the study group of patients than in the control group (p<0.05).Conclusion. In all patients, compared to the control group, the estradiol level was significantly lower (p<0.05), although it did not go beyond the established laboratory norms, progesterone, on the contrary, was higher than normal values, and also significantly exceeded the readings of the control group (p<0.05). Probably, such hyperprogesteronemia, not typical for this period of a woman’s life, along with relative hyperprolactinemia, can cause a milder course of BA in our patients and have a favorable effect on the prognosis of the disease.
format Article
id doaj-art-5417e4e896c74829b298faefa0a4f13d
institution DOAJ
issn 1607-4181
2541-8807
language Russian
publishDate 2025-06-01
publisher Academician I.P. Pavlov First St. Petersburg State Medical University
record_format Article
series Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
spelling doaj-art-5417e4e896c74829b298faefa0a4f13d2025-08-20T03:21:34ZrusAcademician I.P. Pavlov First St. Petersburg State Medical UniversityУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова1607-41812541-88072025-06-01321899710.24884/1607-4181-2025-32-1-89-97713Hormonal status and inflammation in menopausal women with bronchial asthmaA. V. Barkova0V. I. Trofimov1Pavlov UniversityPavlov UniversityIntroduction. At least 348 million patients worldwide suffer from bronchial asthma (BA). It has been established that in women, hormonal status, namely female sex hormones such as estradiol and progesterone, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), contributes to the course and development of BA.The objective was to evaluate hormonal status and inflammation indices in menopausal women suffering from BA.Methods and materials. Our study involved 71 patients suffering from mild to moderate BA, outside of exacerbation of the disease, in menopause. The control group consisted of 16 healthy menopausal women. All subjects underwent determination of the level of estradiol, progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, cortisol, immunoglobulin E, IL-1α, IL-4 and IL-8, nitric oxide (FENO), cytological examination of spontaneous sputum, as well as spirometry with a bronchodilator.Results. In the group of patients with BA, the level of estradiol was almost 2 times lower compared to the control group (p<0.05), while the level of progesterone was, on the contrary, lower in the control group compared to patients with BA (p<0.05). The level of prolactin was almost 2 times lower in the studied group of patients with BA compared to the control group (p<0.05). A higher level of FSH was found in the group of patients with BA compared to the control group (p<0.05), LH levels were practically the same in the study group and the control group, the LH/FSH level was significantly lower in the study group of patients than in the control group (p<0.05).Conclusion. In all patients, compared to the control group, the estradiol level was significantly lower (p<0.05), although it did not go beyond the established laboratory norms, progesterone, on the contrary, was higher than normal values, and also significantly exceeded the readings of the control group (p<0.05). Probably, such hyperprogesteronemia, not typical for this period of a woman’s life, along with relative hyperprolactinemia, can cause a milder course of BA in our patients and have a favorable effect on the prognosis of the disease.https://www.sci-notes.ru/jour/article/view/1128bronchial asthmamenopause, estradiolprogesteronefollicle-stimulating hormoneluteinizing hormoneprolactincortisol
spellingShingle A. V. Barkova
V. I. Trofimov
Hormonal status and inflammation in menopausal women with bronchial asthma
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
bronchial asthma
menopause, estradiol
progesterone
follicle-stimulating hormone
luteinizing hormone
prolactin
cortisol
title Hormonal status and inflammation in menopausal women with bronchial asthma
title_full Hormonal status and inflammation in menopausal women with bronchial asthma
title_fullStr Hormonal status and inflammation in menopausal women with bronchial asthma
title_full_unstemmed Hormonal status and inflammation in menopausal women with bronchial asthma
title_short Hormonal status and inflammation in menopausal women with bronchial asthma
title_sort hormonal status and inflammation in menopausal women with bronchial asthma
topic bronchial asthma
menopause, estradiol
progesterone
follicle-stimulating hormone
luteinizing hormone
prolactin
cortisol
url https://www.sci-notes.ru/jour/article/view/1128
work_keys_str_mv AT avbarkova hormonalstatusandinflammationinmenopausalwomenwithbronchialasthma
AT vitrofimov hormonalstatusandinflammationinmenopausalwomenwithbronchialasthma